| Entry |
|
|---|
| Name |
Teneliximab (USAN/INN) |
|---|
| Efficacy |
Immunosuppressant, Anti-CD40 antibody |
|---|
| Type |
Monoclonal antibody |
|---|
| Comment |
Treatment of auto-immune diseases and prevention of organ transplant rejection
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04060 | Cytokine-cytokine receptor interaction |
| hsa04514 | Cell adhesion molecule (CAM) interaction |
| hsa04620 | Toll-like receptor signaling pathway |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
Tumor necrosis factor receptors
TNFRSF5 (CD40)
D06071 Teneliximab (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
